Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin as adjunct to methadone for OUD and cocaine use
NCT02028533Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin in cocaine use disorder (CUD) and opioid use disorder (OUD), sponsored by University of California, San Francisco. Primary endpoint: Number of patients with non-serious and serious adverse events at 3 weeks. Started Jul 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
cocaine use disorder (CUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02028533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028533.